N-terminal BET bromodomain inhibitors disrupt a BRD4-p65 interaction and reduce inducible nitric oxide synthase transcription in pancreatic ß-cells.
Front Endocrinol (Lausanne)
; 13: 923925, 2022.
Article
in En
| MEDLINE
| ID: mdl-36176467
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Nuclear Proteins
/
Diabetes Mellitus, Type 1
Type of study:
Prognostic_studies
Limits:
Animals
Language:
En
Journal:
Front Endocrinol (Lausanne)
Year:
2022
Document type:
Article
Affiliation country:
Estados Unidos